You are on Trendlyne United States.
Click here
to go to India website or make
United States
as your default
Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Data Downloader
Events Calendar
Explore
FAQs
Widgets
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Login / Sign up
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Cardiff Oncology Inc
Swot
Cardiff Oncology Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Cardiff Oncology Inc has 15 Strengths, 8 Weaknesses, 6 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(15)
Weakness
(8)
Opportunity
(6)
Threats
(0)
Others
(2)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Consistent Highest Return Stocks over Five Years - Nifty500
Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over the Quarter (3 Months)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Company with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Top Gainers
Stock with Low PE (PE < = 10)
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Book Value Per Share deteriorating for last 2 years
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months
Promoters increasing shareholding QoQ
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
